# Using tDCS in Speech-based Stroke Rehabilitation

> **NCT03452202** · NA · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 24 (estimated)

## Conditions studied

- Apraxia of Speech

## Interventions

- **DEVICE:** Soterix 1x1 line tDCS low-intensity stimulator
- **DEVICE:** Sham

## Key facts

- **NCT ID:** NCT03452202
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-11
- **Primary completion:** 2026-10-30
- **Final completion:** 2026-10-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03452202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03452202, "Using tDCS in Speech-based Stroke Rehabilitation". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03452202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*